Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2025-12-27 @ 3:48 PM
Study NCT ID:
NCT01971268
Status:
UNKNOWN
Last Update Posted:
2013-10-29
First Post:
2013-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Compare the Success Rate of T3 Dental Implant (Biomet 3I) With or Without Platform-switch Concept
Sponsor:
Implantology Institute
Organization:
Study Overview
Official Title:
Marginal Bone Behavior of Dental Implants to Different Rehabilitation Protocols
Status:
UNKNOWN
Status Verified Date:
2013-10
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In patients that received a T3 (Biomet 3I) dental implant, does the use of platform-switch concept compared to the use of platform-matched concept, refrain marginal bone loss during osseointegration phase (t=12 weeks =T1) and from then to final rehabilitation (t= placement of the final restoration = at 18 weeks=T2)
Detailed Description:
Patients from a private practice who received dental implants (T3 dental implant Biomet 3I) from November 2012 to October 2013 were eligible to enter the study.
Two groups were formed: one group received a T3 dental implant with platform switch concept and the other received an implant with platform matched type of connection.
We evaluate osseointegration at T1 (12 weeks) and marginal bone position in relation to the implant platform at baseline (implant installation) T0 and again at T1 and T2.
From data recorder in T0,T1 and T2, we evaluate changes in marginal bone position.
Two groups were formed: one group received a T3 dental implant with platform switch concept and the other received an implant with platform matched type of connection.
We evaluate osseointegration at T1 (12 weeks) and marginal bone position in relation to the implant platform at baseline (implant installation) T0 and again at T1 and T2.
From data recorder in T0,T1 and T2, we evaluate changes in marginal bone position.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: